Sitagliptin And Metformin Hydrochloride Tablet, Film Coated
Product Images NDC 70710-1987

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sitagliptin And Metformin Hydrochloride (NDC 70710-1987). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals (usa) Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Dac30601 B2bf 4ec1 Bbee Dcf022990efd 01)

Chemical structure of the active ingredient Sitagliptin, showing its molecular formula with various functional groups including fluorine atoms and a trifluoromethyl group.*

FDA Label Image

Structure (Dac30601 B2bf 4ec1 Bbee Dcf022990efd 02)

Chemical structure diagram of the active ingredient Sitagliptin and Metformin Hydrochloride, showing the molecular arrangement including the HCl component.*

FDA Label Image

Graph (Dac30601 B2bf 4ec1 Bbee Dcf022990efd 03)

Line graph showing the least squares mean change from baseline over 24 weeks for different treatments, including placebo, metformin 1000 mg twice daily, sitagliptin 100 mg daily, and combinations of sitagliptin 50 mg plus metformin at 500 mg or 1000 mg twice daily. The x-axis represents weeks, and the y-axis represents change from baseline values.*

FDA Label Image

Graph (Dac30601 B2bf 4ec1 Bbee Dcf022990efd 04)

A line graph showing the least squares mean change from baseline over 52 weeks for two treatments: Sitagliptin 100 mg and Glipizide. The x-axis represents time in weeks, and the y-axis shows the LS mean change from baseline, illustrating a similar trend in change for both treatments throughout the study period.*

FDA Label Image

Label (Dac30601 B2bf 4ec1 Bbee Dcf022990efd 05)

Packaging label for Sitagliptin and Metformin Hydrochloride tablets, 50 mg/500 mg strength, film-coated oral tablets. The label states it contains 60 tablets and is distributed by Zydus Pharmaceuticals (USA) Inc. Storage instructions and a note to dispense the enclosed Medication Guide are included. The NDC 70710-1986-6 and barcode are visible.*

FDA Label Image

Label (Dac30601 B2bf 4ec1 Bbee Dcf022990efd 06)

Label for Sitagliptin and Metformin Hydrochloride Tablets 50 mg/1,000 mg film-coated oral tablets. The label includes dosage strength, 60 tablets per package, and instructions to dispense the enclosed Medication Guide. It is labeled by Zydus Pharmaceuticals (USA) Inc., with manufacturing by Zydus Lifesciences Ltd. The label also contains storage instructions, child resistance warning, and contact information for medication guide access.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.